skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Nywening, Timothy M, MD ; Wang-Gillam, Andrea, MD ; Sanford, Dominic E, MD ; Belt, Brian A, MA ; Panni, Roheena Z, MD ; Cusworth, Brian M, BA ; Toriola, Adetunji T, MD ; Nieman, Rebecca K, MS ; Worley, Lori A, BS ; Yano, Motoyo, MD ; Fowler, Kathryn J, MD ; Lockhart, A Craig, MD ; Suresh, Rama, MD ; Tan, Benjamin R, MD ; Lim, Kian-Huat, MD ; Fields, Ryan C, MD ; Strasberg, Steven M, Prof ; Hawkins, William G, Prof ; DeNardo, David G, PhD ; Goedegebuure, S Peter, PhD ; Linehan, David C, Dr Prof

The lancet oncology, 2016-05, Vol.17 (5), p.651-662 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
12
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

Fujitani, Kazumasa, MD ; Yang, Han-Kwang, Prof ; Mizusawa, Junki, MSc ; Kim, Young-Woo, MD ; Terashima, Masanori, MD ; Han, Sang-Uk, MD ; Iwasaki, Yoshiaki, MD ; Hyung, Woo Jin, MD ; Takagane, Akinori, MD ; Park, Do Joong, MD ; Yoshikawa, Takaki, MD ; Hahn, Seokyung, PhD ; Nakamura, Kenichi, MD ; Park, Cho Hyun, MD ; Kurokawa, Yukinori, MD ; Bang, Yung-Jue, Prof ; Park, Byung Joo, Prof ; Sasako, Mitsuru, Prof ; Tsujinaka, Toshimasa, Dr

The lancet oncology, 2016-03, Vol.17 (3), p.309-318 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
13
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs
Material Type:
Artigo 		Adicionar ao Meu Espaço

The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs

Grosse, Scott D ; Nelson, Richard E ; Nyarko, Kwame A ; Richardson, Lisa C ; Raskob, Gary E

Thrombosis research, 2016-01, Vol.137, p.3-10 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
14
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial

Untch, Michael, Prof ; Jackisch, Christian, Prof ; Schneeweiss, Andreas, Prof ; Conrad, Bettina, MD ; Aktas, Bahriye, MD ; Denkert, Carsten, Prof ; Eidtmann, Holger, MD ; Wiebringhaus, Hermann, MD ; Kümmel, Sherko, MD ; Hilfrich, Jörn, Prof ; Warm, Mathias, Prof ; Paepke, Stefan, MD ; Just, Marianne, MD ; Hanusch, Claus, MD ; Hackmann, John, MD ; Blohmer, Jens-Uwe, Prof ; Clemens, Michael, Prof ; Darb-Esfahani, Silvia, MD ; Schmitt, Wolfgang Daniel, MD ; Dan Costa, Serban, Prof ; Gerber, Bernd, Prof ; Engels, Knut, MD ; Nekljudova, Valentina, PhD ; Loibl, Sibylle, Prof ; von Minckwitz, Gunter, Prof

The lancet oncology, 2016-03, Vol.17 (3), p.345-356 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
15
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Ford, Hugo E R, Dr ; Marshall, Andrea, PhD ; Bridgewater, John A, PhD ; Janowitz, Tobias, PhD ; Coxon, Fareeda Y, MRCP ; Wadsley, Jonathan, FRCR ; Mansoor, Wasat, PhD ; Fyfe, David, MD ; Madhusudan, Srinivasan, FRCP ; Middleton, Gary W, Prof ; Swinson, Daniel, MD ; Falk, Stephen, MD ; Chau, Ian, MD ; Cunningham, David, Prof ; Kareclas, Paula, PhD ; Cook, Natalie, PhD ; Blazeby, Jane M, Prof ; Dunn, Janet A, Prof

The lancet oncology, 2014, Vol.15 (1), p.78-86 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
16
How I treat multiple myeloma in geriatric patients
How I treat multiple myeloma in geriatric patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

How I treat multiple myeloma in geriatric patients

Facon, Thierry ; Leleu, Xavier ; Manier, Salomon

Blood, 2024-01, Vol.143 (3), p.224-232 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
17
Idarucizumab for dabigatran reversal – Does one dose fit all?
Idarucizumab for dabigatran reversal – Does one dose fit all?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Idarucizumab for dabigatran reversal – Does one dose fit all?

Rottenstreich, Amihai ; Jahshan, Nivin ; Avraham, Limor ; Kalish, Yosef

Thrombosis research, 2016-10, Vol.146, p.103-104 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
18
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial

Dimopoulos, Meletios A, Dr Prof ; Trotman, Judith, Prof ; Tedeschi, Alessandra, MD ; Matous, Jeffrey V, Prof ; Macdonald, David, MD ; Tam, Constantine, MBBS ; Tournilhac, Olivier, Prof ; Ma, Shuo, MD ; Oriol, Albert, MD ; Heffner, Leonard T, MD ; Shustik, Chaim, Prof ; García-Sanz, Ramón, Prof ; Cornell, Robert F, MD ; de Larrea, Carlos Fernández, MD ; Castillo, Jorge J, MD ; Granell, Miquel, MD ; Kyrtsonis, Marie-Christine, MD ; Leblond, Veronique, Prof ; Symeonidis, Argiris, MD ; Kastritis, Efstathios, MD ; Singh, Priyanka, MS ; Li, Jianling, MS ; Graef, Thorsten, MD ; Bilotti, Elizabeth, MSN ; Treon, Steven, MD ; Buske, Christian, Prof

The lancet oncology, 2017-02, Vol.18 (2), p.241-250 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
19
Effect of Donor Sex on Recipient Mortality in Transfusion
Effect of Donor Sex on Recipient Mortality in Transfusion
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Donor Sex on Recipient Mortality in Transfusion

Chassé, Michaël ; Fergusson, Dean A. ; Tinmouth, Alan ; Acker, Jason P. ; Perelman, Iris ; Tuttle, Angie ; English, Shane W. ; Hawken, Steven ; Forster, Alan J. ; Shehata, Nadine ; Thavorn, Kednapa ; Wilson, Kumanan ; Cober, Nancy ; Maddison, Heather ; Tokessy, Melanie

The New England journal of medicine, 2023-04, Vol.388 (15), p.1386-1395 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
20
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

Rudin, Charles M, Prof ; Pietanza, M Catherine, MD ; Bauer, Todd M, MD ; Ready, Neal, Prof ; Morgensztern, Daniel, MD ; Glisson, Bonnie S, Prof ; Byers, Lauren A, MD ; Johnson, Melissa L, MD ; Burris, Howard A, MD ; Robert, Francisco, Prof ; Han, Tae H, PhD ; Bheddah, Sheila, BA ; Theiss, Noah, MS ; Watson, Sky, BS ; Mathur, Deepan, MD ; Vennapusa, Bharathi, MD ; Zayed, Hany, PhD ; Lally, Satwant, MS ; Strickland, Donald K, MD ; Govindan, Ramaswamy, Prof ; Dylla, Scott J, PhD ; Peng, Stanford L, MD ; Spigel, David R, MD

The lancet oncology, 2017-01, Vol.18 (1), p.42-51 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (79.008)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (80.905)
  2. Newsletter Articles  (22)
  3. Web Resources  (3)
  4. magazinearticle  (2)
  5. Livros  (1)
  6. Book Chapters  (1)
  7. Mais opções open sub menu

Assunto 

  1. Humans  (80.849)
  2. Science & Technology  (79.494)
  3. Life Sciences & Biomedicine  (78.743)
  4. Middle Aged  (69.768)
  5. Female  (68.762)
  6. Male  (65.366)
  7. Hematology  (60.753)
  8. Adult  (52.674)
  9. Oncology  (39.344)
  10. Aged, 80 And Over  (30.908)
  11. Hematology, Oncology And Palliative Medicine  (23.947)
  12. Biological And Medical Sciences  (22.237)
  13. Medical Sciences  (21.961)
  14. Treatment Outcome  (15.608)
  15. Adolescent  (15.457)
  16. Retrospective Studies  (15.381)
  17. Prognosis  (13.778)
  18. Young Adult  (13.500)
  19. Risk Factors  (10.653)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1967  (51)
  2. 1967Até1980  (604)
  3. 1981Até1994  (2.330)
  4. 1995Até2009  (25.595)
  5. Após 2009  (52.368)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (80.902)
  2. Japonês  (12.719)
  3. Alemão  (60)
  4. Norueguês  (28)
  5. Francês  (23)
  6. Russo  (20)
  7. Português  (18)
  8. Espanhol  (9)
  9. Chinês  (7)
  10. Sueco  (1)
  11. Persa  (1)
  12. Turco  (1)
  13. Coreano  (1)
  14. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.